ad image

Recombinant Proteins

1 / 1
Navigating the Complexities of Microbial and Mammalian Manufacturing
CDMO

Navigating the Complexities of Microbial and Mammalian Manufacturing

Peter Boman; Helena Pettersson

NorthX Biologics

PAO-12-24-CL-3Jan 02, 2025
The Expanding Role for Recombinant Proteins in Research
Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

Rob Burgess, Ph.D.

Sino Biological

PAO-11-22-PATV-01Jan 06, 2023
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
Recombinant Antibodies

Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing

Rob Burgess, Ph.D.; Amy Sheng, Ph.D.; Lilith Elmore

Sino Biological

PAO-04-022-CL-01Apr 07, 2022
HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice
Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

evitria AG

PAO-03-022-CL-22Mar 22, 2022
Meeting the Renewed Demand for Microbial Protein Production
Recombinant Proteins

Meeting the Renewed Demand for Microbial Protein Production

Grifols Recombinant Protein CDMO

PAO-01-22-R250-07Jan 28, 2022
Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology
Single-Use Technology

Facilitating Clinical Manufacturing of Recombinant Proteins with Large-Scale Single-Use Fermentation Technology

Scott Doncaster; Cameron Graham; Neil Morrison

BIOVECTRA

PAO-10-21-CL-08-778Oct 20, 2021
Sovereign's Capital
M&A

Sovereign Backs the Bioscript Team to Expand the Business

Sovereign's Capital

PR-M06-21-012Jun 04, 2021
Richter BioLogics
Capacity Expansion

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand

Richter BioLogics

PR-M05-21-008May 12, 2021
Innovation and Flexibility Drive Success During the COVID-19 Pandemic
Recombinant Proteins

Innovation and Flexibility Drive Success During the COVID-19 Pandemic

Paul Magreta

Grifols Recombinant Protein CDMO

PAP-Q3-20-CL-019Sep 29, 2020
Leveraging a Biomanufacturing Legacy to Support New Business
Virtual Panel

Leveraging a Biomanufacturing Legacy to Support New Business

Grifols Recombinant Protein CDMO

PAP-Q1-20-CL-005Mar 19, 2020
Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods
Analytical Development

Solving Process Challenges Requires Flexibility to Explore Alternative Analytical Methods

Shaonly Saha

Grifols Recombinant Protein CDMO

PAP-Q4-19-CL-017Dec 06, 2019
Proprietary Protein Therapeutics with Clinically Improved Profiles
Plant-Based

Proprietary Protein Therapeutics with Clinically Improved Profiles

Dror Bashan

Protalix BioTherapeutics

PAP-Q4-19-CL-028Dec 06, 2019
Inhibrx, Inc.
Patient Enrollment

Inhibrx Announces Enrollment of First Patient in Phase 1 Study of INBRX-101, a Modified Recombinant Human AAT-Fc Fusion Protein

Inhibrx, Inc.

PR-M09-19-NI-023Sep 10, 2019
New Facility Presents Manufacturing Solutions for Recombinant Proteins
Recombinant Proteins

New Facility Presents Manufacturing Solutions for Recombinant Proteins

Paul Magreta

Grifols Recombinant Protein CDMO

PAP-Q2-2019-CL-019May 24, 2019
Plant-based Protein Expression for Rapid, Green Bioprocessing
Plant-Based Solutions

Plant-based Protein Expression for Rapid, Green Bioprocessing

Robert Erwin

iBio, Inc.

PAP-Q2-2019-CL-022May 24, 2019
1 / 1